Bank of New York Mellon Corp Has $1,170,000 Stake in Axcelis Technologies Inc. (ACLS)
Bank of New York Mellon Corp boosted its stake in Axcelis Technologies Inc. (NASDAQ:ACLS) by 0.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 434,821 shares of the company’s stock after buying an additional 226 shares during the period. Bank of New York Mellon Corp owned approximately 1.50% of Axcelis Technologies worth $1,170,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of the company. UBS Group AG raised its stake in Axcelis Technologies by 16.3% in the first quarter. UBS Group AG now owns 862,095 shares of the company’s stock valued at $2,414,000 after buying an additional 120,544 shares during the last quarter. Primecap Management Co. CA raised its stake in Axcelis Technologies by 1.0% in the first quarter. Primecap Management Co. CA now owns 13,809,200 shares of the company’s stock valued at $38,666,000 after buying an additional 135,000 shares during the last quarter. Adirondack Research & Management Inc. raised its stake in Axcelis Technologies by 6.9% in the first quarter. Adirondack Research & Management Inc. now owns 1,582,353 shares of the company’s stock valued at $4,431,000 after buying an additional 101,700 shares during the last quarter. Metropolitan Life Insurance Co. NY raised its stake in Axcelis Technologies by 0.6% in the first quarter. Metropolitan Life Insurance Co. NY now owns 83,766 shares of the company’s stock valued at $235,000 after buying an additional 461 shares during the last quarter. Finally, Keane Capital Partners LLC purchased a new stake in Axcelis Technologies during the first quarter valued at $772,000.
Shares of Axcelis Technologies Inc. (NASDAQ:ACLS) traded up 1.8445% on Friday, reaching $13.8203. 67,448 shares of the company traded hands. Axcelis Technologies Inc. has a one year low of $7.16 and a one year high of $14.14. The company has a market capitalization of $402.97 million, a P/E ratio of 36.3692 and a beta of 1.56. The firm’s 50 day moving average is $12.79 and its 200 day moving average is $11.33.
Axcelis Technologies (NASDAQ:ACLS) last announced its quarterly earnings results on Tuesday, August 2nd. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.06. Axcelis Technologies had a return on equity of 6.18% and a net margin of 4.19%. The business earned $64.45 million during the quarter, compared to the consensus estimate of $66.04 million. During the same quarter last year, the firm posted $0.05 EPS. The company’s quarterly revenue was down 17.8% on a year-over-year basis. Analysts expect that Axcelis Technologies Inc. will post $0.37 earnings per share for the current fiscal year.
ACLS has been the topic of several analyst reports. B. Riley reaffirmed a “buy” rating and issued a $4.00 target price on shares of Axcelis Technologies in a report on Monday, June 20th. Zacks Investment Research upgraded shares of Axcelis Technologies from a “hold” rating to a “buy” rating and set a $11.00 price target on the stock in a research report on Tuesday, July 5th. Finally, TheStreet upgraded shares of Axcelis Technologies from a “hold” rating to a “buy” rating in a research report on Friday, August 5th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Axcelis Technologies presently has a consensus rating of “Buy” and a consensus target price of $8.50.
In other news, EVP William J. Bintz sold 5,751 shares of Axcelis Technologies stock in a transaction on Monday, August 8th. The stock was sold at an average price of $11.98, for a total transaction of $68,896.98. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Arthur L. George, Jr. bought 5,000 shares of the company’s stock in a transaction dated Friday, August 5th. The shares were purchased at an average cost of $11.24 per share, with a total value of $56,200.00. Following the acquisition, the director now directly owns 27,987 shares of the company’s stock, valued at approximately $314,573.88. The disclosure for this purchase can be found here. Insiders own 5.13% of the company’s stock.
About Axcelis Technologies
Axcelis Technologies, Inc designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The Company operates through the manufacture of capital equipment for the semiconductor manufacturing industry segment. The Company sells its equipment to semiconductor chip manufacturers across the world.
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies Inc. (NASDAQ:ACLS).
Receive News & Ratings for Axcelis Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.